Article Content

Women do not need a clinic visit with a pelvic exam or ultrasound for safe and effective medication abortion, a study in the May JAMA Internal Medicine indicates. With the pandemic, many clinics began offering medication abortion after eligibility was determined through history-based screening alone. The researchers examined data on 3,779 abortions performed at 14 clinics using history-based screening. There was no statistically significant difference in effectiveness rates between those who received medications via mail and those who got them in person (93% versus 95%, respectively). Neither was there any statistically significant difference in the rate of major abortion-related adverse events: 0.76% for mail receipt and 0.54% for in-person receipt. Women in rural and low-income areas already face barriers to accessing safe abortions, and with increasing state restrictions on abortion, those barriers-financial, transportation, legal, and others-will mount for many women. These findings show that telehealth- and mail-dispensed medications are an option that can, as the authors note, "increase equitable access to abortion for all patients."